Ontology highlight
ABSTRACT:
PROVIDER: PRJNA592380 | ENA |
REPOSITORIES: ENA
Similar Datasets
Project description:Henosepilachna vigintioctomaculata Transcriptome
| PRJNA418210 | ENA
Project description:Henosepilachna vigintioctopunctata Transcriptome
| PRJNA415902 | ENA
Project description:Henosepilachna vigintioctopunctata overview
| PRJNA527899 | ENA
Project description:mRNA seq analysis of Henosepilachna vigintioctopunctata
| PRJDB8592 | ENA
Project description:Henosepilachna vigintioctopunctata Transcriptome or Gene expression
| PRJNA530163 | ENA
Project description:H9 human embryonic stem cells (hESCs) were cultured in feeder-free chemically-defined conditions in medium containing 10ng/ml Activin A and 12ng/ml FGF2 (Vallier L. 2011, Methods in Molecular Biology, 690: 5766). Chromatin immunoprecipitation was performed as described in Brown S. et al. 2011. Stem Cells 29: 117685 by using 5ug of anti-DPY30 antibody (Sigma, cat. number HPA043761). This protocol was performed in control hESCs (expressing a scrambled shRNA) and in hESCs stably expressing an shRNA against DPY30 (Sigma, clone n. TRCN0000131112).This data is part of a pre-publication release. For information on the proper use of pre-publication data shared by the Wellcome Trust Sanger Institute (including details of any publication moratoria), please see http://www.sanger.ac.uk/datasharing/
2016-05-18 | E-ERAD-365 | biostudies-arrayexpress
Project description:The BLUEPRINT project is a large-scale project investigating epigenetic mechanisms involved in blood formation, in health and disease. The human variation workpackage (WP10) of the project seeks to characterize the effect of common sequence variation on the epigenome status of a cell. To do this, the project will use highly purified blood cells to minimise experimental noise and therefore enhance the power to discover modest effects. Two peripheral blood cell types, the CD14+CD16- monocyte (an important central orchestrator of adaptive immunity and a bridge between innate and adaptive immunity) and the CD65+CD9- neutrophilic granulocyte (the frontline cell for innate immunity) have been selected for this purpose. The two types of cells will be obtained at high purity from adult blood (AB) of 200 healthy males and females, respectively. Cells will be purified by using already validated and fully operational protocols that are based on density gradient centrifugation of the buffy coat obtained from whole blood, followed by magnetic bead-based purification using monoclonal antibodies against Cluster of Differentiation (CD) lineage-specific cell surface markers. This data set contains functional genomics data for gene expression and chromatin state.
2015-11-17 | E-ERAD-214 | biostudies-arrayexpress
Project description:TraDIS study to identify novel immunity proteins and their effector proteins associated with the Type VI secretion system (T6SS) in Pseudomonas aeruginosaThese data are part of a pre-publication release. For information on the proper use of pre-publication data shared by the Wellcome Trust Sanger Institute (including details of any publication moratoria), please see http://www.sanger.ac.uk/datasharing/
2015-05-12 | E-ERAD-317 | biostudies-arrayexpress